Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62–Keap1–NRF2 pathway

被引:0
|
作者
Yanchun Li
Bing Xu
Xueying Ren
Luyang Wang
Yaqing Xu
Yefeng Zhao
Chen Yang
Chen Yuan
Huanjuan Li
Xiangmin Tong
Ying Wang
Jing Du
机构
[1] Zhejiang University School of Medicine,Department of Central Laboratory, Affiliated Hangzhou First People’s Hospital
[2] Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital,Department of Clinical Laboratory, Laboratory Medicine Center
[3] Hangzhou Medical College),Department of Clinical Laboratory
[4] Hangzhou Women’s Hospital,Department of Laboratory Medicine
[5] The Second Affiliated Hospital of Zhejiang Chinese Medical University,undefined
来源
Cellular & Molecular Biology Letters | 2022年 / 27卷
关键词
CISD2; Iron; Autophagy; Ferroptosis; Ferritinophagy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Nobiletin Induces Ferroptosis in Human Skin Melanoma Cells Through the GSK3β-Mediated Keap1/Nrf2/HO-1 Signalling Pathway
    Feng, Senling
    Zhou, Yongheng
    Huang, Hongliang
    Lin, Ying
    Zeng, Yifeng
    Han, Shanshan
    Huang, Kaikai
    Liu, Quanzhi
    Zhu, Wenting
    Yuan, Zhongwen
    Liang, Baoying
    FRONTIERS IN GENETICS, 2022, 13
  • [32] Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway
    Wang, Weiqi
    Zhong, Xin
    Fang, Zimin
    Li, Jianmin
    Li, Hebo
    Liu, Xuesheng
    Yuan, Xindi
    Huang, Weijian
    Huang, Zhouqing
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 377
  • [33] Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis
    Zheng, Xiang-jin
    Chen, Wen-lin
    Yi, Jie
    Li, Wan
    Liu, Jin-yi
    Fu, Wei-qi
    Ren, Li-wen
    Li, Sha
    Ge, Bin-bin
    Yang, Yi-hui
    Zhang, Yi-zhi
    Yang, Hong
    Du, Guan-hua
    Wang, Yu
    Wang, Jin-hua
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (11) : 2977 - 2992
  • [34] p62-Dependent Phase Separation of Patient-Derived KEAP1 Mutations and NRF2
    Cloer, E. W.
    Siesser, P. F.
    Cousins, E. M.
    Goldfar, D.
    Mowrey, D. D.
    Harrison, J. S.
    Weir, S. J.
    Dokholyan, N. V.
    Major, M. B.
    MOLECULAR AND CELLULAR BIOLOGY, 2018, 38 (22)
  • [35] Sestrin2 reduces ferroptosis via the Keap1/Nrf2 signaling pathway after intestinal ischemia-reperfusion
    Zhang, Le-le
    Ding, Ke
    Liao, Shi-shi
    Zhang, Yi-guo
    Liao, Hui-yang
    Chen, Rong
    Meng, Qing-tao
    FREE RADICAL BIOLOGY AND MEDICINE, 2024, 214 : 115 - 128
  • [36] Sarmentosin alleviates doxorubicin-induced cardiotoxicity and ferroptosis via the p62-Keap1-Nrf2 pathway
    Lin, Zhihui
    Wu, Chang
    Song, Dongyan
    Zhu, Chenxi
    Wu, Bosen
    Wang, Jie
    Xue, Yangjing
    REDOX REPORT, 2024, 29 (01)
  • [37] Exosomes inhibit ferroptosis to alleviate intervertebral disc degeneration via the p62-KEAP1-NRF2 pathway
    Chen, Chao
    Wang, Xuenan
    Zhao, Yueqin
    Duan, Xianle
    Hu, Yaoquan
    Lv, Zhengpin
    He, Qicong
    Yangyang, Zijiu
    Wu, Guishuai
    Luo, Haoyan
    Zuo, Qianlin
    Hao, Xiaojiang
    Zhao, Yuhan
    Ding, Xiao
    Zhang, Fan
    FREE RADICAL BIOLOGY AND MEDICINE, 2025, 232 : 171 - 184
  • [38] Curcumin activates Nrf2 through PKCδ-mediated p62 phosphorylation at Ser351
    Park, Jee-Yun
    Sohn, Hee-Young
    Koh, Young Ho
    Jo, Chulman
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [39] Dihydromyricetin modulates p62 and autophagy crosstalk with the Keap-1/Nrf2 pathway to alleviate ethanol-induced hepatic injury
    Qiu, Ping
    Dong, Yu
    Li, Bo
    Kang, Xian-jie
    Gu, Chao
    Zhu, Tao
    Luo, Yun-yun
    Pang, Min-xia
    Du, Wei-feng
    Ge, Wei-hong
    TOXICOLOGY LETTERS, 2017, 274 : 31 - 41
  • [40] LRRK2 Mediates α-Synuclein-Induced Neuroinflammation and Ferroptosis through the p62-Keap1-Nrf2 Pathway in Parkinson's Disease
    Liu, Xinjie
    Zheng, Zijian
    Xue, Cheng
    Wang, Xiangrong
    Li, Jianwei
    Liu, Zheng
    Xin, Wenqiang
    Xu, Xinping
    Zhou, Dongwei
    Yao, Longping
    Lu, Guohui
    INFLAMMATION, 2025,